CStone Pharmaceuticals (HKG:2616) Chief Executive Officer Jianxin Yang increased his holding in the drug company by 560,000 shares, according to a Wednesday filing with the Hong Kong bourse.
Yang purchased the shares at a price ranging from HK$2.26 to HK$3.29 apiece, the filing said.
Since beginning in his role as CEO, Yang has bought 10,359,000 shares, or 5.46% of the total shareholding of CStone.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。